Kyocera International will purchase the major assets of Renovis Surgical Technologies' operations related to its artificial joint and spine products.
Three things to know:
1. In March, the assets will be transferred into a new company wholly-owned by Kyocera International called Kyocera Medical Technologies.
2. Kyocera manufactures artificial joints and dental implants, among other products. The company received FDA 510(k) clearance for its artificial hip joints and began selling them in the U.S. in 2017.
3. Kyocera plans to expand its U.S. medical equipment business through this purchase.